Nephrology
Clinical
Apixaban a reasonable alternative to warfarin in patients with severe renal impairment
Is apixaban a safe alternative to warfarin in patients with severe renal impairment?
Clinical
Timing of initiation of renal-replacement therapy in acute kidney injury
In critically ill patients, does early renal-replacement therapy (RRT), compared with standard therapy, improve death from any cause at 90 days?...
Clinical
Comparing the efficacy and safety of common SIADH treatments
Is fluid restriction or the addition of furosemide with or without NaCl supplementation more efficacious for the treatment of hyponatremia caused...
Clinical
What makes a urinary tract infection complicated?
There are multiple interpretations of complicated UTIs.
Clinical
Timing of renal-replacement therapy for AKI in the ICU
Does earlier initiation of renal-replacement therapy (RRT) improve mortality in the ICU?
News
Advanced CKD doesn’t derail empagliflozin in EMPEROR-preserved
Study shows empagliflozin led to a consistent, significant relative risk reduction compared with placebo in the primary endpoint.
News
Fluoroquinolones linked to sudden death risk for those on hemodialysis
Most patients undergoing hemodialysis have a least one risk factor for drug-induced QT interval prolongation.
Clinical
ACE-I or ARB therapy in patients with low eGFR
Is it safe to continue angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) therapy in patients whose...
News
U.S. kidney transplants grow in number and success
Data from 1996 to 2019 show more U.S. kidney transplants recently than ever before, and steady improvements in graft and patient survival.
News
SGLT2 inhibitor use rising in patients with DKD